Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Neuroscience ; 435: 112-123, 2020 05 21.
Article de Anglais | MEDLINE | ID: mdl-32272151

RÉSUMÉ

Acquired information is stabilized into long-term memory through a process known as consolidation. Though, after consolidation, when stored information is retrieved they can be again susceptible, allowing modification, updating and strengthening and to be re-stabilized they need a new process referred to as memory reconsolidation. However, the molecular mechanisms of recognition memory consolidation and reconsolidation are not fully understood. Also, considering that the study of the link between synaptic proteins is key to understanding of memory processes, we investigated, in male Wistar rats, molecular mechanisms in the hippocampus involved on object recognition memory (ORM) consolidation and reconsolidation. We verified that the blockade of AMPA receptors (AMPAr) and L-VDCCs calcium channels impaired ORM consolidation and reconsolidation when administered into CA1 immediately after sample phase or reactivation phase and that these impairments were blocked by the administration of AMPAr agonist and of neurotrophin BDNF. Also, the blockade of CaMKII impaired ORM consolidation when administered 3 h after sample phase but had no effect on ORM reconsolidation and its effect was blocked by the administration of BDNF, but not of AMPAr agonist. So, this study provides new evidence of the molecular mechanisms involved on the consolidation and reconsolidation of ORM, demonstrating that AMPAr and L-VDCCs are necessary for the consolidation and reconsolidation of ORM while CaMKII is necessary only for the consolidation and also that there is a link between BDNF and AMPAr, L-VDCCs and CaMKII as well as a link between AMPAr and L-VDCCs on ORM consolidation and reconsolidation.


Sujet(s)
Consolidation de la mémoire , Animaux , Hippocampe , Mâle , Mémoire , Rats , Rat Wistar ,
2.
Behav Brain Res ; 326: 303-306, 2017 05 30.
Article de Anglais | MEDLINE | ID: mdl-28341611

RÉSUMÉ

Extinction is defined as the learned inhibition of retrieval and is the mainstay of exposure therapy, which is widely used to treat drug addiction, phobias and fear disorders. The psychostimulant, methylphenidate (MPH) is known to increase extracellular levels of noradrenaline and dopamine by blocking their reuptake and studies have demonstrated that MPH can modulate hippocampal physiology and/or functions including long-term potentiation (LTP), learning and memory. However, the influence of MPH on fear extinction memory has been insufficiently studied. Here we investigate the effect of MPH infused into the CA1 region of the hippocampus on extinction memory in animals normally incapable of showing contextual fear conditioning (CFC) extinction because of weak training, and the possible mechanisms through which it acts during this process. For this, male Wistar rats with infusion cannulae stereotaxically implanted in the CA1 region were submitted to a weak extinction protocol in a CFC apparatus. Animals that received intra-CA1 infusion of MPH (12.5µg/side) 20min before the extinction training (Ext Tr) expressed less freezing behavior than Veh-treated animals during both Ext Tr and extinction retention Test (Ext Test). Additionally, the administration of MPH+Timolol (1µg/side) or MPH+SCH23390 (1.5µg/side) intra-CA1 20min before the Ext Tr blocked the enhancing effect of the MPH on extinction learning. These results suggest that MPH in the CA1 region of the hippocampus is able to induce the consolidation of extinction memory and this process occurs through both ß-adrenergic and D1/D5 dopaminergic receptors.


Sujet(s)
Antagonistes bêta-adrénergiques/pharmacologie , Comportement animal/effets des médicaments et des substances chimiques , Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Stimulants du système nerveux central/pharmacologie , Antagonistes de la dopamine/pharmacologie , Extinction (psychologie)/effets des médicaments et des substances chimiques , Consolidation de la mémoire/effets des médicaments et des substances chimiques , Méthylphénidate/pharmacologie , Récepteurs bêta-adrénergiques/physiologie , Récepteurs dopaminergiques/physiologie , Antagonistes bêta-adrénergiques/administration et posologie , Animaux , Benzazépines/administration et posologie , Benzazépines/pharmacologie , Stimulants du système nerveux central/administration et posologie , Conditionnement classique/effets des médicaments et des substances chimiques , Antagonistes de la dopamine/administration et posologie , Peur/effets des médicaments et des substances chimiques , Mâle , Rats , Rat Wistar , Récepteurs bêta-adrénergiques/effets des médicaments et des substances chimiques , Récepteurs dopaminergiques/effets des médicaments et des substances chimiques , Récepteur dopamine D1/antagonistes et inhibiteurs , Timolol/administration et posologie , Timolol/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...